Quantcast
Investor's Business Daily investors.com 07 Nov, 2023 17:30 am

Small Biotech Crashes 82% After Psoriasis Treatment Flops

Small Biotech Crashes 82% After Psoriasis Treatment Flops
Ventyx Biosciences scrapped a psoriasis drug that didn't pass muster in Phase 2 testing on Tuesday, and VTYX stock crashed more than 80%.
Read full story at investors.com